Treeway Is A Clinical Stage Biotechnology Company Based In The Netherlandsfounded In 2012 By Two Als Patientsbernard Muller And Robbert Jan Stuitthe Company Is Dedicated To Developing Therapies For Alsamyotrophic Lateral Sclerosisand Other Neurodegenerative Diseasesincluding Alzheimer S Diseasetreeway S Mission Is To Create Drugs That Delay Disease Progression And Ultimately Aim For A Cure For Als The Company Is Actively Developing Two Drug Therapiestw001 And Tw002With Promising Results From The Phase I Trial Of Tw001Treeway Collaborates With Various Pharmaceutical Companiesngosuniversitiesand Research Centers Across Europeasiaand The United States To Advance Its Drug Development Programsadditionallytreeway Initiated Project Minea Large Scale Research Initiative Focused On Uncovering The Genetic Causes Of Alsunder The Leadership Of Ceo Inez De Greef Aevan Der Sandttreeway Emphasizes Patient Empowerment And Strong Relationships With Als Researchers And Doctors Worldwide
No conferences found for this company.
| Company Name | Treeway Bv |
| Country |
Netherlands
|
| Address | N/A |
| Telephone | N/A |
| N/A |
